Half-year report · Q2
2269.TEDINET S100UP1S
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥569.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥1.11T | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥546.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥44.4bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥44.4bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥43.3bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥76.0bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥43.4bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥44.3bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥48.1bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥26.9bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥50.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥27.9bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥29.5bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥30.4bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥1.18T | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥1.21T | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥1.21T | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥401.2bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥417.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥774.6bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥787.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥786.7bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥78.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥106.9bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥73.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥102.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥78.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥60.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.8bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥108.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥25.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥12.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥24.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥17.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥43.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥97.66 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.64 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.13 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 62.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥318m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥318m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥1.8bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥455.4bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥455.1bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥307m |
| jpcrp040300-q2r_E21902-000Foodreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥27.6bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥113.9bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥113.9bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥10m |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥18.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥569.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥569.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥318m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥46.2bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥303m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥303m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥1.1bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥445.5bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥445.2bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥293m |
| jpcrp040300-q2r_E21902-000Foodreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥29.7bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥100.9bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥100.8bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥9m |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥15.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥546.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥546.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥303m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥45.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 542
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)高 田 慎 司 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)衣 川 清 隆 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)平 岡 亜 惟 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 546047000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 569006000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 1105494000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 43433000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 43347000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 76020000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 27921000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 26867000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 50675000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 48185000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 25985000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 63401000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 786685000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 774553000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 787793000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 1207796000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 1175765000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 1205288000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 100.13 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 97.66 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 181.64 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.617 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.622 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.619 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 25899000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 3760000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 107983000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -15316000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -12188000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -24604000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 4353000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -17404000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -43772000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 78423000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 73377000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 102832000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 293459000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 293459000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 293459000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 293459000 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 41235000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |